Inventor · disambiguated record
John Beamond Nicholas
Also filed as: NICHOLAS JOHN B · NICHOLAS JOHN BEAMOND
11 granted patents·13 pending applications·75 citations·filing 2010–2022
89Inventor score
Top patents by PatentIndex Score
24 records- 0194US10934261B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·15 cites·44 claims
- 0294US10590084B2Cyclic keto-amide compounds as calpain modulators and methods of production and use thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Mar 17, 2020·20 cites·19 claims
- 0390US9675593B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2016·Granted Jun 13, 2017·10 cites·24 claims
- 0489US9359379B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2013·Granted Jun 7, 2016·12 cites·21 claims
- 0586US10376497B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2017·Granted Aug 13, 2019·5 cites·37 claims
- 0682US10233195B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2015·Granted Mar 19, 2019·4 cites·31 claims
- 0780US10898474B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2019·Granted Jan 26, 2021·1 cites·63 claims
- 0879US8975235B2Lysophosphatidic acid receptor antagonistsBUCKMAN BRAD O·Filed 2012·Granted Mar 10, 2015·8 cites·35 claims
- 0971US2022324814A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1066US11339130B1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·0 cites·46 claims
- 1153US10544161B2Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2019·Granted Jan 28, 2020·0 cites·20 claims
- 1244US2014200215A1Lysophosphatidic acid receptor antagonistsINTERMUNE INC·Filed 2013·Application pending·0 cites
- 1344US2014213538A1Lysophosphatidic acid receptor antagonistsINTERMUNE INC·Filed 2014·Application pending·0 cites
- 1443US2014094456A1Anti-fibrotic pyridinonesINTERMUNE INC·Filed 2013·Application pending·0 cites
- 1540US2012095211A1Substituted proline inhibitors of hepatitis c virus replicationBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 1640US2021347727A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1739US11292801B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Apr 5, 2022·0 cites·22 claims
- 1839US2012101032A1Novel macrocyclic inhibitors of hepatitis c virus replicationBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 1939US2012094897A1Novel inhibitors of hepatitis c virus replicationBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 2038US2011312996A1Novel inhibitors of hepatitis c virus replicationBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 2137US2011129444A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
- 2237US2011152246A1Novel inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
- 2337US2012251493A1Novel macrocyclic inhibitors of hepatitis c virus replicationSEIWERT SCOTT D·Filed 2010·Application pending·0 cites
- 2437US2011081315A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Beamond Nicholas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →